STOCK TITAN
  1. Home
  2. Sec-filings
  3. RANI
  4. [EFFECT] Rani Therapeutics Holdings, Inc. SEC Filing

[EFFECT] Rani Therapeutics Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreibe den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreibe den folgenden Text um:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: S-3
CIK: 0001856725
Company Name: Rani Therapeutics Holdings, Inc.
File Number: 333-288509

Source: View Original Filing on SEC EDGAR

Stock RANI logo
Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

RANI Rankings

#6802 Ranked by Market Cap
N/A Ranked by Dividends
#11 Top Loser

RANI Latest News

Jul 14, 2025
Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery 
May 19, 2025
Rani Therapeutics Announces Research Agreement with Chugai
May 13, 2025
Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update
Mar 31, 2025
Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
Mar 26, 2025
Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

RANI Latest SEC Filings

Jul 11, 2025
[424B5] Rani Therapeutics Holdings, Inc. Prospectus Supplement (Debt Securities)
Jul 10, 2025
[DEF 14C] Rani Therapeutics Holdings, Inc. Definitive Information Statement
Jul 3, 2025
[S-3] Rani Therapeutics Holdings, Inc. Shelf Registration Statement
Jun 30, 2025
[PRE 14C] Rani Therapeutics Holdings, Inc. Preliminary Information Statement
Jun 26, 2025
[8-K] Rani Therapeutics Holdings, Inc. Reports Material Event

RANI Stock Data

18.00M
24.24M
27.31%
10.85%
7.4%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN JOSE